Drug, Diagnostic Firms Should Partner, Not Merge, To Personalize Medicine

The drug and diagnostic industries should partner, not merge, to develop companion products, according to a diagnostics industry representative on a recent Personalized Medicine Coalition conference panel

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet